ArticleCancers2026

Discovery of Structurally Distinct Covalent KRAS G12C Inhibitor Scaffolds Through Large-Scale In Silico Screening and Experimental Validation.

Glen J Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.